In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

Pfizer’s subsidiary Biohaven has agreed to a settlement nearing $60 million to resolve allegations of false claims related to improper physician remuneration. This settlement marks a pivotal moment in ...

Sometime in the future, as you are watching your favorite television show or sporting event, amongst the DTC ads featuring ...

In the final days of the Biden Administration, the United States Food and Drug Administration (FDA) issued final guidance on ...

OIG’s Office of Audit Services released its latest report on providers’ compliance with the Hospital Price Rule (the HPT Rule ...

In the final scene of Raiders of the Lost Ark, Indiana Jones watches helplessly as the Ark of the Covenant, despite his ...

Two former CEOs were recently convicted for their roles in a scheme to lie to investors in a publicly traded biotechnology ...

McKinsey & Company Inc., a management consulting firm, recently agreed to pay $650 million to resolve a civil and criminal ...

In a recent episode of Oncology Unscripted, Dr. John Marshall, a renowned oncologist from Georgetown University, delves into the complex economics of cancer care in early 2025. As the new ...

We’ve previously written about state prescription drug affordability review boards (PDABs) that have been instituted around ...

Recently, Dr. Kenneth Fishberger pled guilty in federal court to one count of conspiracy to commit health care fraud for receiving… ...

Dr. Kenneth Fishberger pled guilty in federal court to one count of conspiracy to commit health care fraud for receiving ...